APA (7th ed.) Citation

Elizabeth Marrett, Winghan Jacqueline Kwong, Jipan Xie, Ameur M. Manceur, Selvam R. Sendhil, Eric Wu, . . . Janakiraman Subramanian. (2023). Treatment Patterns and Adverse Event-Related Hospitalization Among Patients with Epidermal Growth Factor Receptor (EGFR)-Mutated Metastatic Non-small Cell Lung Cancer After Treatment with EGFR Tyrosine Kinase Inhibitor and Platinum-Based Chemotherapy Regimens. Adis, Springer Healthcare.

Chicago Style (17th ed.) Citation

Elizabeth Marrett, Winghan Jacqueline Kwong, Jipan Xie, Ameur M. Manceur, Selvam R. Sendhil, Eric Wu, Raluca Ionescu-Ittu, and Janakiraman Subramanian. Treatment Patterns and Adverse Event-Related Hospitalization Among Patients with Epidermal Growth Factor Receptor (EGFR)-Mutated Metastatic Non-small Cell Lung Cancer After Treatment with EGFR Tyrosine Kinase Inhibitor and Platinum-Based Chemotherapy Regimens. Adis, Springer Healthcare, 2023.

MLA (9th ed.) Citation

Elizabeth Marrett, et al. Treatment Patterns and Adverse Event-Related Hospitalization Among Patients with Epidermal Growth Factor Receptor (EGFR)-Mutated Metastatic Non-small Cell Lung Cancer After Treatment with EGFR Tyrosine Kinase Inhibitor and Platinum-Based Chemotherapy Regimens. Adis, Springer Healthcare, 2023.